期刊文献+

加味阳和汤对膝骨性关节炎病患MMP-3、MMP-9水平的影响研究 被引量:16

Effects of Jiawei Yanghe decoction for knee osteoarthritis patients MMP-3,MMP-9 level
下载PDF
导出
摘要 目的:通过对比研究,分析加味阳和汤对膝骨性关节炎(OA)病患血清MMP-3基质金属蛋白酶-3、MMP-9(基质金属蛋白酶-9)的影响,探讨其治疗效果。方法 :以骨伤科收诊的138例膝关节OA病患为研究对象,随机分为治疗组和对照组。两组病患均给予双氯芬酸钠缓释片100mg,连续服用4周。其中治疗组同时加用加味阳和汤。对两组血清MMP-3、MMP-9水平治疗前后的变化进行对比,分析其临床疗效。结果:经过治疗后显示,治疗组和对照组病患MMP-3与MMP-9的水平均下降显著,治疗组明显低于对照组,治疗组总有效率(97.01%)显著高于对照组(84.06%)。两组不良反应对比差异无意义。结论:在治疗膝关节OA时,加味阳和汤可以降低病患血清MMP-3、MMP-9水平,保护软骨基质和细胞,拥有很好的疗效。 Objective:Through the comparative study of Jiawei Yanghe decoction on knee osteoarthritis(osteoarthritis)disease patients serum MMP-3,MMP-9,and to explore its therapeutic effect.Methods:In our hospital of orthopedics and traumatology diagnosis of 138 cases of knee joint OA disease patients as the research object,were randomly divided into study group and control group.Two groups of patients were once daily oral administration diclofenac sodium sustained release tablet(100mg),administered for 4weeks.The research group combined with modified Yanghe decoction.The changes of serum MMP-3and MMP-9levels in the two groups were compared before and after treatment,and the clinical effects were analyzed.Results:After treatment,the levels of MMP-9and MMP-3in the study group and the control group were decreased significantly,and the total effective rate in the study group(97.01%)was significantly higher than that in the control group(84.06%).There was no significant difference between the two groups in adverse reactions.Conclusion:In the treatment of knee osteoarthritis,modified Yanghe Decoction can reduce disease patient serum levels of MMP-3,MMP-9levels,protect the cartilage matrix and cells and has a good curative effect.
作者 张晨 马建强
出处 《陕西中医》 2016年第2期201-203,共3页 Shaanxi Journal of Traditional Chinese Medicine
基金 2012年首都卫生发展科研专项课题(首发2011-1006-01)
关键词 骨关节炎 膝/中医药疗法 阳和汤/治疗应用 Osteoarthritis knee/traditional Chinese medicine therapy Yang He Tang/therapeutic uses
  • 相关文献

参考文献9

二级参考文献94

  • 1卢思俭,姜全心,王成.益肾为主对兔膝骨关节炎模型软骨细胞凋亡的影响[J].山东中医杂志,2006,25(10):696-698. 被引量:6
  • 2莫晓枫,梁若茄.腹针治疗原发性骨质疏松症的临床观察[J].中国中医药科技,2007,14(5):315-315. 被引量:5
  • 3Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum, 2000, 43: 1905-1915. 被引量:1
  • 4Schnitzer TJ, American College of Rheumatology. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage, 2002, 23(4 Suppl): S24-34. 被引量:1
  • 5Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅱ. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum, 1995, 38:1541-1546. 被引量:1
  • 6Hochberg MC, Ahman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part Ⅰ. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum, 1995, 38: 1535-1540. 被引量:1
  • 7Simon LS, Lipman AG, Jacox AK, eds. Pain in osteoarthritis, rheumatoid arthritis and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society (APS), 2002. 179. 被引量:1
  • 8Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2007, 66: 377-388. 被引量:1
  • 9Zhang W, Doherty M. EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology. Br J Sports Med, 2006, 40: 664-669. 被引量:1
  • 10Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2000, 59: 936-944. 被引量:1

共引文献2102

同被引文献218

引证文献16

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部